Related Experiment Video
Updated: Jun 18, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Interventions to Facilitate Shared Decision-Making Using Decision Aids with Coronary Heart Disease Patients:
Haoyang Zheng1, Duo Zhang2, Wei Xiang1
1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, China.
Insights
Shared decision-making (SDM) using patient decision aids improves knowledge and reduces conflict for coronary heart disease (CHD) patients. This approach enhances decision quality and treatment outcomes in CHD management.
Area of Science:
- Cardiology
- Health Decision Science
- Evidence-Based Medicine
Background:
- Coronary heart disease (CHD) is a leading global cause of mortality.
- Managing CHD involves complex decisions regarding chest pain, treatments, and stent selection, often complicated by unstable patient conditions.
- Shared decision-making (SDM) with decision aids can improve decision quality but has not been evaluated in CHD.
Purpose of the Study:
- To systematically review and assess the effects of SDM interventions on patients with coronary heart disease.
- To evaluate the impact of SDM on decision-making quality and treatment outcomes in CHD patients.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) of SDM interventions in CHD patients.
- Searched multiple databases (PubMed, Embase, Cochrane, Web of Science, CNKI, Wan Fang) from inception to June 2022.
- Primary outcomes: patient knowledge and decision conflict. Secondary outcomes: satisfaction, participation, trust, acceptance, quality of life, and psychological condition.
Main Results:
- Ten studies involving 8244 retrieved articles were included.
- SDM interventions significantly improved patient knowledge, decision satisfaction, participation, and medical outcomes compared to control groups.
- SDM interventions effectively reduced decision-making conflict, with no significant impact on patient trust.
Conclusions:
- SDM interventions, particularly using patient decision aids, are beneficial for improving decision-making quality and treatment outcomes in patients with CHD.
- Further evaluation of SDM interventions in diverse settings is warranted to confirm these benefits.
Background:
Coronary heart disease (CHD) is the leading cause of death in the world. There are some decision-making conflicts in the management of chest pain, treatment methods, stent selection, and other aspects due to the unstable condition of CHD in the treatment stage. Although using decision aids to facilitate shared decision-making (SDM) contributes to high-quality decision-making, it has not been evaluated in the field of CHD. This review systematically assessed the effects of SDM in patients with CHD.
Methods:
We conducted a systematic review and meta-analysis of randomized controlled trials of SDM interventions in patients with CHD from database inception to 1 June 2022 (PROSPERO [Unique identifier: CRD42022338938]). We searched for relevant studies in the PubMed, Embase, Cochrane Library, Web of Science, CNKI, and Wan Fang databases. The primary outcomes were knowledge and decision conflict. The secondary outcomes were satisfaction, patient participation, trust, acceptance, quality of life, and psychological condition.
Results:
A total of 8244 studies were retrieved. After screening, ten studies were included in the analysis. Compared with the control group, SDM intervention with patient decision aids obviously improved patients' knowledge, decision satisfaction, participation, and medical outcomes and reduced decision-making conflict. There was no significant effect of SDM on trust.
Conclusions:
This study showed that SDM intervention in the form of decision aids was beneficial to decision-making quality and treatment outcomes among patients with CHD. The results of SDM interventions need to be evaluated in different environments.
More Related Videos
Related Concept Videos
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Ethical Dilemmas II
Heart Failure Drugs: Inotropic Agents
Patient-centered Care

